Lambaudie E, Collinet P, Vinatier D
Service de gynécologie chirurgicale, hôpital Jeanne-de-Flandre, CHRU de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France.
Gynecol Obstet Fertil. 2006 Mar;34(3):254-7. doi: 10.1016/j.gyobfe.2006.01.026. Epub 2006 Mar 10.
The authors propose to report progress on the use of the CA 125 serum assay. It affects three situations: screening, diagnosis and the follow-up of the patients dealt with ovarian tumour either of benign or malignant nature. For each situation the interest and the relevance of CA 125 assay will be approached.